These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 36717813)
1. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line. Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813 [TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a new triple-negative canine mammary cancer cell line. Zhang H; Pei S; Zhou B; Wang H; Du H; Zhang D; Lin D Tissue Cell; 2018 Oct; 54():10-19. PubMed ID: 30309498 [TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a multi-drug resistant cell line for canine mammary tumors. Zhou C; Lin Z; Li X; Zhang D; Song P Front Vet Sci; 2023; 10():1129756. PubMed ID: 37077947 [TBL] [Abstract][Full Text] [Related]
5. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT. Raposo LR; Roma-Rodrigues C; Faísca P; Alves M; Henriques J; Carvalheiro MC; Corvo ML; Baptista PV; Pombeiro AJ; Fernandes AR Vet Comp Oncol; 2017 Sep; 15(3):952-967. PubMed ID: 27140424 [TBL] [Abstract][Full Text] [Related]
6. Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026. Mei C; Xin L; Liu Y; Lin J; Xian H; Zhang X; Hu W; Xia Z; Wang H; Lyu Y Front Vet Sci; 2021; 8():744032. PubMed ID: 34712723 [TBL] [Abstract][Full Text] [Related]
7. A Novel Canine Mammary Cancer Cell Line: Preliminary Identification and Utilization for Drug Screening Studies. Li R; Wu H; Sun Y; Zhu J; Tang J; Kuang Y; Li G Front Vet Sci; 2021; 8():665906. PubMed ID: 34124226 [TBL] [Abstract][Full Text] [Related]
8. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms. Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas. Raposo-Ferreira TMM; Brisson BK; Durham AC; Laufer-Amorim R; Kristiansen V; Puré E; Volk SW; Sorenmo K Vet Pathol; 2018 Sep; 55(5):622-633. PubMed ID: 29788797 [TBL] [Abstract][Full Text] [Related]
10. Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118. Gao H; Zhou H; Gao Y; He L; Li W; Xu M; Feng H; Feng X; Qiu C Vet Comp Oncol; 2022 Sep; 20(3):679-687. PubMed ID: 35429113 [TBL] [Abstract][Full Text] [Related]
11. Characterization of neoplastic cells outlining the cystic space of invasive micropapillary carcinoma of the canine mammary gland. Rodrigues MA; Caldeira-Brant AL; Gomes DA; Silveira TL; Chiarini-Garcia H; Cassali GD BMC Vet Res; 2021 Mar; 17(1):130. PubMed ID: 33761962 [TBL] [Abstract][Full Text] [Related]
12. Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry. Peña L; Gama A; Goldschmidt MH; Abadie J; Benazzi C; Castagnaro M; Díez L; Gärtner F; Hellmén E; Kiupel M; Millán Y; Miller MA; Nguyen F; Poli A; Sarli G; Zappulli V; de las Mulas JM Vet Pathol; 2014 Jan; 51(1):127-45. PubMed ID: 24227007 [TBL] [Abstract][Full Text] [Related]
13. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin. Hellmén E; Moller M; Blankenstein MA; Andersson L; Westermark B Breast Cancer Res Treat; 2000 Jun; 61(3):197-210. PubMed ID: 10965996 [TBL] [Abstract][Full Text] [Related]
14. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines. Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010 [TBL] [Abstract][Full Text] [Related]
15. p63: a novel myoepithelial cell marker in canine mammary tissues. Gama A; Alves A; Gartner F; Schmitt F Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513 [TBL] [Abstract][Full Text] [Related]
16. AE1/AE3, vimentin and p63 immunolocalization in canine mammary gland tumours: roles in differentiation between luminal epithelial and myoepithelial lineages. Toniti P; Sirivisoot S; Jandee P; Srimontri P; Puchadapirom P; Doungchawee G; Kasorndorkbua C Asian Pac J Cancer Prev; 2010; 11(1):227-30. PubMed ID: 20593961 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors. Ramadan ES; Salem NY; Emam IA; AbdElKader NA; Farghali HA; Khattab MS Vet Res Commun; 2022 Jun; 46(2):377-388. PubMed ID: 34787777 [TBL] [Abstract][Full Text] [Related]
18. Myoepithelial cells in canine mammary tumours. Sánchez-Céspedes R; Millán Y; Guil-Luna S; Reymundo C; Espinosa de Los Monteros A; Martín de Las Mulas J Vet J; 2016 Jan; 207():45-52. PubMed ID: 26639832 [TBL] [Abstract][Full Text] [Related]
19. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis. Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897 [TBL] [Abstract][Full Text] [Related]
20. AGR2-mediated unconventional secretion of 14-3-3ε and α-actinin-4, responsive to ER stress and autophagy, drives chemotaxis in canine mammary tumor cells. Yuan SH; Wu CC; Wang YC; Chan XY; Chu HW; Yang Y; Liu HP Cell Mol Biol Lett; 2024 May; 29(1):84. PubMed ID: 38822246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]